Niklas Huntemann
Muenster, NW 48151, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Delivering high-quality multiple sclerosis care in Germany: challenges and regional models.
Journal: Neurological research and practice
Published: July 04, 2026
Investigating the role of serum IL-6 in predicting outcomes of b-cell depleting therapy in multiple sclerosis: a retrospective cohort study.
Journal: BMC neurology
Published: February 15, 2026
Early versus late add-on therapy in generalized myasthenia gravis: a multicenter real-world cohort study.
Journal: Journal of neurology
Published: December 24, 2025
Multicentric prognostic observational study on biomarker profile in immunotherapy-naïve patients with highly active generalized myasthenia gravis (PROGNO-MG): a study protocol.
Journal: Neurological research and practice
Published: November 11, 2025
Case-Based Lessons on Remote Patient Monitoring in Neurology Using Consumer-Grade Wearables.
Journal: Journal of central nervous system disease
Published: August 14, 2025
Digital Activity Markers in Chronic Inflammatory Demyelinating Polyneuropathy.
Journal: Annals of clinical and translational neurology
Published: February 27, 2025
CD19xCD3 T cell engager blinatumomab effective in refractory generalized myasthenic syndromes.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 18, 2025
C5 complement inhibition versus FcRn modulation in generalised myasthenia gravis.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: June 05, 2024
Identification of disease phenotypes in acetylcholine receptor-antibody myasthenia gravis using proteomics-based consensus clustering.
Journal: EBioMedicine
Published: March 04, 2024
Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravis.
Journal: Acta neuropathologica
Published: February 15, 2024
Last Updated: 09/26/2026